Patents by Inventor Erik Philipp

Erik Philipp has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11013761
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Grant
    Filed: January 15, 2021
    Date of Patent: May 25, 2021
    Assignee: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD.
    Inventors: Ludwig Daniel Weibel, Erik Philipp
  • Patent number: 11013762
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Grant
    Filed: January 15, 2021
    Date of Patent: May 25, 2021
    Assignee: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD.
    Inventors: Ludwig Daniel Weibel, Erik Philipp
  • Publication number: 20210137973
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Application
    Filed: January 15, 2021
    Publication date: May 13, 2021
    Applicant: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
    Inventors: Ludwig Daniel WEIBEL, Erik PHILIPP
  • Publication number: 20210128608
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Application
    Filed: January 15, 2021
    Publication date: May 6, 2021
    Applicant: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
    Inventors: Ludwig Daniel WEIBEL, Erik PHILIPP
  • Publication number: 20210115163
    Abstract: A water soluble iron carbohydrate complex obtainable from an aqueous solution of iron(III) salt and an aqueous solution of the oxidation product of one or more maltrodextrins using an aqueous hypochlorite solution at a pH-value within the alkaline range, where, when one maltodextrin is applied, its dextrose equivalent lies between 5 and 20, and when a mixture of several maltodextrins is applied, the dextrose equivalent of the mixture lies between 5 and 20 and the dextrose equivalent of each individual maltodextrin contained in the mixture lies between 2 and 40, a process for its production and a medicament for the treatment and prophylaxis of iron deficiency conditions.
    Type: Application
    Filed: December 23, 2020
    Publication date: April 22, 2021
    Inventors: Peter Geisser, Erik Philipp, Walter Richle
  • Patent number: 10933090
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Grant
    Filed: July 17, 2020
    Date of Patent: March 2, 2021
    Assignee: Vifor Fresenius Medical Care Renal Pharma Ltd
    Inventors: Ludwig Daniel Weibel, Erik Philipp
  • Publication number: 20210054105
    Abstract: A water soluble iron carbohydrate complex obtainable from an aqueous solution of iron(III) salt and an aqueous solution of the oxidation product of one or more maltrodextrins using an aqueous hypochlorite solution at a pH-value within the alkaline range, where, when one maltodextrin is applied, its dextrose equivalent lies between 5 and 20, and when a mixture of several maltodextrins is applied, the dextrose equivalent of the mixture lies between 5 and 20 and the dextrose equivalent of each individual maltodextrin contained in the mixture lies between 2 and 40, a process for its production and a medicament for the treatment and prophylaxis of iron deficiency conditions.
    Type: Application
    Filed: November 2, 2020
    Publication date: February 25, 2021
    Inventors: Peter Geisser, Erik Philipp, Walter Richle
  • Patent number: 10925897
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: February 23, 2021
    Assignee: Vifor Fresenius Medical Care Renal Pharma Ltd
    Inventors: Ludwig Daniel Weibel, Erik Philipp
  • Patent number: 10925896
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Grant
    Filed: June 19, 2020
    Date of Patent: February 23, 2021
    Assignee: Vifor Fresenius Medical Care Renal Pharma Ltd
    Inventors: Ludwig Daniel Weibel, Erik Philipp
  • Publication number: 20200345766
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Application
    Filed: July 17, 2020
    Publication date: November 5, 2020
    Applicant: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
    Inventors: Ludwig Daniel WEIBEL, Erik PHILIPP
  • Publication number: 20200316112
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Application
    Filed: June 19, 2020
    Publication date: October 8, 2020
    Applicant: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
    Inventors: Ludwig Daniel WEIBEL, Erik PHILIPP
  • Publication number: 20200316111
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Application
    Filed: June 19, 2020
    Publication date: October 8, 2020
    Applicant: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
    Inventors: Ludwig Daniel WEIBEL, Erik PHILIPP
  • Patent number: 10780113
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Grant
    Filed: December 23, 2016
    Date of Patent: September 22, 2020
    Assignee: Vifor Fresenius Medical Care Renal Pharma Ltd.
    Inventors: Ludwig Daniel Weibel, Erik Philipp
  • Publication number: 20200222327
    Abstract: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
    Type: Application
    Filed: March 16, 2020
    Publication date: July 16, 2020
    Applicant: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD.
    Inventors: Laurent CHOFFLON, Erik PHILIPP
  • Publication number: 20200222328
    Abstract: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
    Type: Application
    Filed: March 16, 2020
    Publication date: July 16, 2020
    Applicant: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD.
    Inventors: Laurent CHOFFLON, Erik PHILIPP
  • Patent number: 10695367
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Grant
    Filed: November 27, 2018
    Date of Patent: June 30, 2020
    Assignee: Vifor Fresenius Medical Care Renal Pharma Ltd
    Inventors: Ludwig Daniel Weibel, Erik Philipp
  • Patent number: 10682376
    Abstract: Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
    Type: Grant
    Filed: October 25, 2018
    Date of Patent: June 16, 2020
    Assignee: Vifor Fresenius Medical Care Renal Pharma Ltd
    Inventors: Ludwig Daniel Weibel, Erik Philipp
  • Patent number: 10624855
    Abstract: The present invention relates to pharmaceutical composition, comprising certain phosphate binder particles having a certain particle size distribution, a process for the manufacture of the pharmaceutical composition and the use of sucroferric oxyhydroxide having a certain particle size distribution for the manufacture of a pharmaceutical composition.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: April 21, 2020
    Assignee: Vifor Fresenius Medical Care Renal Pharma Ltd.
    Inventors: Laurent Chofflon, Erik Philipp
  • Publication number: 20200113885
    Abstract: The invention relates to novel salts of compounds of the general formula (I), pharmaceutical compositions comprising them and the use thereof as medicaments, in particular for the use as ferroportin inhibitors, more particularly for the use in the prophylaxis and/or treatment of diseases caused by a lack of hepcidin or iron metabolism disorders, such as particularly iron overload states such as in particular thalassemia, sickle cell disease and hemochromatosis.
    Type: Application
    Filed: April 18, 2018
    Publication date: April 16, 2020
    Inventors: Collin D. Morris, Fritz Blatter, Giuseppe Lapadula, Stefan Reim, Michael Burgert, Erik Philipp
  • Patent number: 10519252
    Abstract: Water soluble Iron carbohydrate complex obtainable from an aqueous solution of iron(III) salt and an aqueous solution of the oxidation product of one or more maltrodextrins using an aqueous hypochlorite solution at a pH-value within the alkaline range, where, when one maltodextrin is applied, its dextrose equivalent lies between 5 and 20, and when a mixture of several maltodextrins is applied, the dextrose equivalent of the mixture lies between 5 and 20 and the dextrose equivalent of each individual maltodextrin contained in the mixture lies between 2 and 40, process for its production and medicament for the treatment and prophylaxis of iron deficiency conditions.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: December 31, 2019
    Assignee: VIFOR (INTERNATIONAL) AG.
    Inventors: Peter Geisser, Erik Philipp, Walter Richle